Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration
Journal of Clinical Microbiology · 26.01.2023 · 61 (1)
DOI: 10.1128/jcm.01086-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 26.01.2023. Verfasst von Hui-Jin Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
The World Health Organization recently lowered the rifampin (RIF) critical concentration (CC) for drug-susceptibility testing (DST) of Mycobacterium tuberculosis complex (MTBC) using the mycobacterial growth indicator tube (MGIT) 960 system. Here, we evaluated the diagnostic performance of the MGIT system with the revised CC for determining MTBC RIF resistance with 303 clinical MTBC isolates, including 122 isolates with rpoB mutations, of which 32 had single borderline-resistance mutations, and 181 wild-type rpoB isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Sungkyunkwan University School of Medicine, Suwon, South Korea.
- Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Korean National Tuberculosis Association, Korean Institute of Tuberculosis, Cheongju, South Korea.
- Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, South Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
ORCID-Profile: Tae Yeul Kim, Byung Woo Jhun, Hee Jae Huh
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Yu, H. J., Kim, T. Y., Kim, G., Shim, H. J., Kang, O. K., Kim, S., Kim, C. K., Jhun, B. W., Lee, N. Y., Huh, H. J., & Lee, H. J. (2023). Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration. Journal of Clinical Microbiology, 61(1). https://doi.org/10.1128/jcm.01086-22
Vancouver
Yu HJ, Kim TY, Kim G, Shim HJ, Kang OK, Kim S, et al. Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration. Journal of Clinical Microbiology. 2023;61(1). doi:10.1128/jcm.01086-22
BibTeX
@article{Yu2023,
author = {Yu, Hui-Jin and Kim, Tae Yeul and Kim, Gangmin and Shim, Hyang Jin and Kang, On Kyun and Kim, Seungmo and Kim, Chang-Ki and Jhun, Byung Woo and Lee, Nam Yong and Huh, Hee Jae and Lee, Hee Joo},
title = {Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration},
journal = {Journal of Clinical Microbiology},
year = {2023},
volume = {61},
number = {1},
doi = {10.1128/jcm.01086-22}
}
EUVIMED